Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO17249 | Lespedeza capitata | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO28771 | Clematis delavayi | Species | Ranunculaceae | Eukaryota | UNPD* | |||
NPO21344 | Fadogia agrestis | Species | Rubiaceae | Eukaryota | UNPD* | |||
NPO24672 | Helleborus purpurascens | Species | Ranunculaceae | Eukaryota | UNPD* | |||
NPO8943 | Juniperus californica | Species | Cupressaceae | Eukaryota | UNPD* | |||
NPO19008 | Mentha cablin | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO25128 | Panax vietnamensis | Species | Araliaceae | Eukaryota | UNPD* | |||
NPO18596 | Melia dubia | Species | Meliaceae | Eukaryota | UNPD* | |||
NPO18259 | Chaetanthera chilensis | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO25321 | Acantholimon glumaceum | Species | Plumbaginaceae | Eukaryota | UNPD* | |||
NPO21534 | Ostrya carpinifolia | Species | Betulaceae | Eukaryota | UNPD* | |||
NPO19721 | Impatiens roylei | Species | Balsaminaceae | Eukaryota | UNPD* | |||
NPO18950 | Cephalotaxus fortunei | Species | Taxaceae | Eukaryota | UNPD* | |||
NPO27620.1 | Pteris cretica var. nervosa | Varieties | Pteridaceae | Eukaryota | TCMID* | |||
NPO18529 | Salvia broussoneti | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO23489 | Stachys anisochila | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO5676 | Annulohypoxylon multiforme | Species | Xylariaceae | Eukaryota | UNPD* | |||
NPO24591 | Trichosanthes dioica | Species | Cucurbitaceae | Eukaryota | UNPD* | |||
NPO16772 | Piper rusbyi | Species | Piperaceae | Eukaryota | Leaves |
PMID[17354169] |
||
NPO24549 | Scutellaria cordifrons | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO20691 | Echinocereus merkeri | Species | Cactaceae | Eukaryota | UNPD* | |||
NPO26193 | Piper methysticum | Species | Piperaceae | Eukaryota |
PMID[11830162] |
|||
NPO8788 | Renealmia nicolaioides | Species | Zingiberaceae | Eukaryota |
PMID[12444686] |
|||
NPO26193 | Piper methysticum | Species | Piperaceae | Eukaryota | Root |
PMID[25597012] |
||
NPO24821 | Nidorella resedifolia | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO16885 | Phonus arborescens | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO24735 | Cupania latifolia | Species | Sapindaceae | Eukaryota | UNPD* | |||
NPO18762 | Ilex microdonta | Species | Aquifoliaceae | Eukaryota | UNPD* | |||
NPO25468 | Tabernaemontana amygdalifolia | Species | Apocynaceae | Eukaryota | UNPD* | |||
NPO20584 | Cheilanthes fragrans | Species | Pteridaceae | Eukaryota | UNPD* | |||
NPO8171 | Artocarpus altilis | Species | Moraceae | Eukaryota | UNPD* | |||
NPO22500 | Stephania dielsiana | Species | Menispermaceae | Eukaryota | UNPD* | |||
NPO21600 | Aconitum variegatum | Species | Ranunculaceae | Eukaryota | UNPD* | |||
NPO25557 | Alternaria porri | Species | Pleosporaceae | Eukaryota | UNPD* | |||
NPO10407 | Petromyzon marinus | Species | Petromyzontidae | Eukaryota | UNPD* | |||
NPO19082 | Creolophus cirrhatus | Species | Hericiaceae | Eukaryota | UNPD* | |||
NPO25410 | Manilkara bidentata | Species | Sapotaceae | Eukaryota | UNPD* | |||
NPO24866 | Smilax aspera | Species | Smilacaceae | Eukaryota | UNPD* | |||
NPO22637 | Kunzea ambigua | Species | Myrtaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 20000 | nM | 11720850 |
NPT111 | Cell Line | K562 | Homo sapiens | Activity | = | 28 | % | 18293907 |
NPT440 | Individual Protein | Quinone oxidoreductase | Mus musculus | CD | = | 1.7 | ug/ml | 12444686 |
NPT2 | Others | Unspecified | IC50 | > | 20000 | nM | 19883086 | |
NPT2 | Others | Unspecified | IC50 | = | 8 | ug/ml | 19716299 | |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 25118.9 | nM | PubChem BioAssay data set |
NPT1038 | Individual Protein | Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 17782.8 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 14125.4 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 14125.4 | nM | PubChem BioAssay data set |
NPT54 | Individual Protein | Nonstructural protein 1 | Influenza A virus | Potency | = | 11220.2 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 31622.8 | nM | PubChem BioAssay data set | |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT524 | Individual Protein | Serine-protein kinase ATM | Homo sapiens | Potency | = | 28183.8 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | IC50 | = | 3300 | nM | 21112783 | |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | 22387.2 | nM | PubChem BioAssay data set | |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | 14125.4 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 20587.8 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 14125.4 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 63095.7 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 18526 | nM | PubChem BioAssay data set | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 10000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 8912.5 | nM | PubChem BioAssay data set | ||
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 10691 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 3784.43 | nM | PubChem BioAssay data set | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 3288.52 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 5970.35 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 8729.71 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 5834.45 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 3723.92 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 7726.81 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 1207.81 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 3784.43 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 9268.3 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 4613.18 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 4425.88 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 7095.78 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 5370.32 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 12022.64 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 3801.89 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 4602.57 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 3639.15 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 23878.11 | nM | PubChem BioAssay data set | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 7638.36 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 3467.37 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 1849.27 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 6546.36 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 3845.92 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 2421.03 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 3515.6 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 7943.28 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 5164.16 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 3854.78 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 7998.34 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 2290.87 | nM | PubChem BioAssay data set | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 4466.84 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 4623.81 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 2971.67 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 10327.61 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 4508.17 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 5636.38 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 4977.37 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 10399.2 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 6095.37 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 7798.3 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 11614.49 | nM | PubChem BioAssay data set | |
NPT888 | Individual Protein | 78 kDa glucose-regulated protein | Homo sapiens | Potency | 22387.2 | nM | PubChem BioAssay data set | |
NPT888 | Individual Protein | 78 kDa glucose-regulated protein | Homo sapiens | Potency | 10000 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 6823.39 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 3539.97 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 5284.45 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 4140 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 4709.77 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 13031.67 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 4528.98 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 3198.9 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 4623.81 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 10789.47 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 2269.86 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 4149.54 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 7655.97 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 3341.95 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 12502.59 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 14521.12 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 101 | % | 22239485 |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 191 | % | 22239485 |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | Inhibition | = | 67.9 | % | 22449016 |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | Inhibition | = | 60.4 | % | 22449016 |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 29092.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 14125.4 | nM | PubChem BioAssay data set | ||
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 27.15 | % | 23062825 |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 4.56 | % | 23062825 |
NPT2 | Others | Unspecified | Potency | 18356.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 25929 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 14581 | nM | PubChem BioAssay data set | ||
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 29092.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 1220000 | nM | 23567958 | |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 141.41 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 125.2 | % | 23571415 |
NPT2 | Others | Unspecified | Potency | 12589.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 22387.2 | nM | PubChem BioAssay data set | ||
NPT535 | Individual Protein | Parathyroid hormone receptor | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 11220.2 | nM | PubChem BioAssay data set | ||
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 4.9 | ug/ml | 25137491 | |
NPT2 | Others | Unspecified | IC50 | = | 7700 | nM | 25597012 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC188646 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC263670 |
1.0 | High Similarity | NPC56031 |
1.0 | High Similarity | NPC175098 |
1.0 | High Similarity | NPC242294 |
1.0 | High Similarity | NPC337373 |
1.0 | High Similarity | NPC139813 |
1.0 | High Similarity | NPC312318 |
1.0 | High Similarity | NPC472365 |
1.0 | High Similarity | NPC192304 |
0.9922 | High Similarity | NPC286336 |
0.9921 | High Similarity | NPC257756 |
0.9921 | High Similarity | NPC212631 |
0.9921 | High Similarity | NPC205468 |
0.9921 | High Similarity | NPC87231 |
0.9921 | High Similarity | NPC129132 |
0.9844 | High Similarity | NPC18877 |
0.9844 | High Similarity | NPC20560 |
0.9844 | High Similarity | NPC159623 |
0.9844 | High Similarity | NPC144051 |
0.9844 | High Similarity | NPC28753 |
0.9844 | High Similarity | NPC294593 |
0.9844 | High Similarity | NPC204960 |
0.9844 | High Similarity | NPC82225 |
0.9843 | High Similarity | NPC64359 |
0.9843 | High Similarity | NPC308037 |
0.9843 | High Similarity | NPC262359 |
0.9769 | High Similarity | NPC168105 |
0.9769 | High Similarity | NPC477242 |
0.9769 | High Similarity | NPC66349 |
0.9769 | High Similarity | NPC472367 |
0.9769 | High Similarity | NPC476333 |
0.9769 | High Similarity | NPC473391 |
0.9769 | High Similarity | NPC98115 |
0.9769 | High Similarity | NPC472364 |
0.9769 | High Similarity | NPC150399 |
0.9769 | High Similarity | NPC249606 |
0.9769 | High Similarity | NPC12165 |
0.9769 | High Similarity | NPC186838 |
0.9769 | High Similarity | NPC41461 |
0.9769 | High Similarity | NPC25287 |
0.9769 | High Similarity | NPC477243 |
0.9769 | High Similarity | NPC1486 |
0.9769 | High Similarity | NPC274109 |
0.9769 | High Similarity | NPC477244 |
0.9695 | High Similarity | NPC472419 |
0.9695 | High Similarity | NPC153979 |
0.9695 | High Similarity | NPC188879 |
0.9695 | High Similarity | NPC317119 |
0.9692 | High Similarity | NPC131039 |
0.9692 | High Similarity | NPC13575 |
0.9692 | High Similarity | NPC156092 |
0.9688 | High Similarity | NPC475008 |
0.9688 | High Similarity | NPC309717 |
0.9688 | High Similarity | NPC186097 |
0.9688 | High Similarity | NPC128348 |
0.9688 | High Similarity | NPC313618 |
0.9688 | High Similarity | NPC66384 |
0.9688 | High Similarity | NPC112192 |
0.9688 | High Similarity | NPC164236 |
0.9688 | High Similarity | NPC189106 |
0.9688 | High Similarity | NPC475009 |
0.9685 | High Similarity | NPC247779 |
0.9621 | High Similarity | NPC21350 |
0.9621 | High Similarity | NPC124269 |
0.9621 | High Similarity | NPC472368 |
0.9618 | High Similarity | NPC240593 |
0.9618 | High Similarity | NPC213603 |
0.9615 | High Similarity | NPC103842 |
0.9606 | High Similarity | NPC211120 |
0.9549 | High Similarity | NPC470211 |
0.9549 | High Similarity | NPC472366 |
0.9549 | High Similarity | NPC477956 |
0.9545 | High Similarity | NPC266597 |
0.9545 | High Similarity | NPC116632 |
0.9545 | High Similarity | NPC303644 |
0.9545 | High Similarity | NPC162680 |
0.9545 | High Similarity | NPC7013 |
0.9545 | High Similarity | NPC209560 |
0.9545 | High Similarity | NPC250266 |
0.9545 | High Similarity | NPC181124 |
0.9545 | High Similarity | NPC294409 |
0.9538 | High Similarity | NPC27643 |
0.9528 | High Similarity | NPC80694 |
0.9528 | High Similarity | NPC186098 |
0.9478 | High Similarity | NPC172250 |
0.9478 | High Similarity | NPC215311 |
0.9478 | High Similarity | NPC213659 |
0.9478 | High Similarity | NPC48624 |
0.9478 | High Similarity | NPC11056 |
0.9478 | High Similarity | NPC259166 |
0.9478 | High Similarity | NPC219917 |
0.9478 | High Similarity | NPC326109 |
0.9478 | High Similarity | NPC204985 |
0.9478 | High Similarity | NPC144118 |
0.9478 | High Similarity | NPC80962 |
0.9474 | High Similarity | NPC471620 |
0.9474 | High Similarity | NPC90665 |
0.9474 | High Similarity | NPC251681 |
0.9474 | High Similarity | NPC279668 |
0.9474 | High Similarity | NPC278323 |
0.9474 | High Similarity | NPC99333 |
0.9474 | High Similarity | NPC309154 |
0.9474 | High Similarity | NPC243528 |
0.9474 | High Similarity | NPC55162 |
0.9474 | High Similarity | NPC12175 |
0.9474 | High Similarity | NPC188947 |
0.9474 | High Similarity | NPC280284 |
0.947 | High Similarity | NPC473887 |
0.947 | High Similarity | NPC231772 |
0.947 | High Similarity | NPC29353 |
0.947 | High Similarity | NPC124784 |
0.947 | High Similarity | NPC127447 |
0.947 | High Similarity | NPC13408 |
0.947 | High Similarity | NPC194281 |
0.947 | High Similarity | NPC234133 |
0.947 | High Similarity | NPC47815 |
0.9449 | High Similarity | NPC305518 |
0.9449 | High Similarity | NPC128428 |
0.9407 | High Similarity | NPC55832 |
0.9407 | High Similarity | NPC26051 |
0.9407 | High Similarity | NPC268204 |
0.9407 | High Similarity | NPC469404 |
0.9407 | High Similarity | NPC470087 |
0.9407 | High Similarity | NPC470089 |
0.9407 | High Similarity | NPC321980 |
0.9407 | High Similarity | NPC52789 |
0.9407 | High Similarity | NPC110969 |
0.9407 | High Similarity | NPC49108 |
0.9403 | High Similarity | NPC109232 |
0.9403 | High Similarity | NPC283429 |
0.9403 | High Similarity | NPC295384 |
0.9398 | High Similarity | NPC290291 |
0.9398 | High Similarity | NPC275055 |
0.9394 | High Similarity | NPC39426 |
0.9394 | High Similarity | NPC234560 |
0.938 | High Similarity | NPC185497 |
0.9338 | High Similarity | NPC11561 |
0.9338 | High Similarity | NPC471417 |
0.9338 | High Similarity | NPC119663 |
0.9338 | High Similarity | NPC226636 |
0.9333 | High Similarity | NPC129853 |
0.9333 | High Similarity | NPC253822 |
0.9333 | High Similarity | NPC188243 |
0.9333 | High Similarity | NPC110228 |
0.9333 | High Similarity | NPC6407 |
0.9333 | High Similarity | NPC76445 |
0.9333 | High Similarity | NPC159275 |
0.9333 | High Similarity | NPC69769 |
0.9333 | High Similarity | NPC269652 |
0.9333 | High Similarity | NPC172986 |
0.9333 | High Similarity | NPC270883 |
0.9333 | High Similarity | NPC241100 |
0.9333 | High Similarity | NPC101366 |
0.9333 | High Similarity | NPC265178 |
0.9333 | High Similarity | NPC284550 |
0.9333 | High Similarity | NPC281207 |
0.9333 | High Similarity | NPC261227 |
0.9323 | High Similarity | NPC24394 |
0.9323 | High Similarity | NPC87545 |
0.9323 | High Similarity | NPC235428 |
0.9318 | High Similarity | NPC172262 |
0.9318 | High Similarity | NPC164136 |
0.9313 | High Similarity | NPC15834 |
0.9313 | High Similarity | NPC203817 |
0.9313 | High Similarity | NPC215875 |
0.9313 | High Similarity | NPC10971 |
0.9302 | High Similarity | NPC69235 |
0.9302 | High Similarity | NPC212379 |
0.9302 | High Similarity | NPC60558 |
0.9291 | High Similarity | NPC65041 |
0.927 | High Similarity | NPC149026 |
0.927 | High Similarity | NPC18585 |
0.927 | High Similarity | NPC475705 |
0.927 | High Similarity | NPC117836 |
0.927 | High Similarity | NPC301751 |
0.927 | High Similarity | NPC166138 |
0.927 | High Similarity | NPC175504 |
0.927 | High Similarity | NPC91560 |
0.927 | High Similarity | NPC39329 |
0.927 | High Similarity | NPC75049 |
0.927 | High Similarity | NPC106985 |
0.927 | High Similarity | NPC143896 |
0.927 | High Similarity | NPC257097 |
0.927 | High Similarity | NPC245482 |
0.927 | High Similarity | NPC169591 |
0.927 | High Similarity | NPC51887 |
0.927 | High Similarity | NPC68104 |
0.927 | High Similarity | NPC150408 |
0.927 | High Similarity | NPC310130 |
0.927 | High Similarity | NPC164980 |
0.927 | High Similarity | NPC476178 |
0.927 | High Similarity | NPC221432 |
0.9265 | High Similarity | NPC126534 |
0.9265 | High Similarity | NPC90582 |
0.9265 | High Similarity | NPC3188 |
0.9265 | High Similarity | NPC262094 |
0.9265 | High Similarity | NPC147688 |
0.9265 | High Similarity | NPC232021 |
0.9265 | High Similarity | NPC64908 |
0.9265 | High Similarity | NPC26238 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC188646 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9688 | High Similarity | NPD1240 | Approved |
0.9538 | High Similarity | NPD1607 | Approved |
0.9394 | High Similarity | NPD1510 | Phase 2 |
0.9185 | High Similarity | NPD1549 | Phase 2 |
0.9111 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.9111 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.9065 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.8929 | High Similarity | NPD7410 | Clinical (unspecified phase) |
0.8897 | High Similarity | NPD2796 | Approved |
0.8857 | High Similarity | NPD6799 | Approved |
0.875 | High Similarity | NPD4380 | Phase 2 |
0.869 | High Similarity | NPD7411 | Suspended |
0.8633 | High Similarity | NPD970 | Clinical (unspecified phase) |
0.8592 | High Similarity | NPD1511 | Approved |
0.8581 | High Similarity | NPD3882 | Suspended |
0.8571 | High Similarity | NPD2801 | Approved |
0.8571 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.854 | High Similarity | NPD6651 | Approved |
0.8523 | High Similarity | NPD7075 | Discontinued |
0.8519 | High Similarity | NPD6859 | Clinical (unspecified phase) |
0.8514 | High Similarity | NPD8443 | Clinical (unspecified phase) |
0.8511 | High Similarity | NPD1878 | Clinical (unspecified phase) |
0.8503 | High Similarity | NPD1934 | Approved |
0.8493 | Intermediate Similarity | NPD6599 | Discontinued |
0.8489 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8489 | Intermediate Similarity | NPD2935 | Discontinued |
0.8472 | Intermediate Similarity | NPD1512 | Approved |
0.8446 | Intermediate Similarity | NPD7819 | Suspended |
0.8446 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.84 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.838 | Intermediate Similarity | NPD3750 | Approved |
0.8378 | Intermediate Similarity | NPD6801 | Discontinued |
0.831 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.8284 | Intermediate Similarity | NPD1203 | Approved |
0.8261 | Intermediate Similarity | NPD943 | Approved |
0.8212 | Intermediate Similarity | NPD7768 | Phase 2 |
0.8194 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.8182 | Intermediate Similarity | NPD2800 | Approved |
0.8182 | Intermediate Similarity | NPD2654 | Approved |
0.8169 | Intermediate Similarity | NPD2344 | Approved |
0.8163 | Intermediate Similarity | NPD5403 | Approved |
0.8158 | Intermediate Similarity | NPD3749 | Approved |
0.8146 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8102 | Intermediate Similarity | NPD6832 | Phase 2 |
0.8088 | Intermediate Similarity | NPD2798 | Approved |
0.8077 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8077 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8077 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8077 | Intermediate Similarity | NPD9493 | Approved |
0.8065 | Intermediate Similarity | NPD6232 | Discontinued |
0.806 | Intermediate Similarity | NPD3972 | Approved |
0.806 | Intermediate Similarity | NPD9717 | Approved |
0.8056 | Intermediate Similarity | NPD1243 | Approved |
0.8028 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.8028 | Intermediate Similarity | NPD3748 | Approved |
0.8028 | Intermediate Similarity | NPD2799 | Discontinued |
0.8027 | Intermediate Similarity | NPD5401 | Approved |
0.8027 | Intermediate Similarity | NPD2532 | Approved |
0.8027 | Intermediate Similarity | NPD2534 | Approved |
0.8027 | Intermediate Similarity | NPD2533 | Approved |
0.8025 | Intermediate Similarity | NPD7473 | Discontinued |
0.8 | Intermediate Similarity | NPD6959 | Discontinued |
0.7975 | Intermediate Similarity | NPD3818 | Discontinued |
0.7955 | Intermediate Similarity | NPD9545 | Approved |
0.7945 | Intermediate Similarity | NPD2309 | Approved |
0.7937 | Intermediate Similarity | NPD5953 | Discontinued |
0.7925 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7925 | Intermediate Similarity | NPD7054 | Approved |
0.7925 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7919 | Intermediate Similarity | NPD920 | Approved |
0.7891 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7877 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7875 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7875 | Intermediate Similarity | NPD7472 | Approved |
0.7857 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7852 | Intermediate Similarity | NPD422 | Phase 1 |
0.7852 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7826 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7821 | Intermediate Similarity | NPD5494 | Approved |
0.782 | Intermediate Similarity | NPD1548 | Phase 1 |
0.78 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7792 | Intermediate Similarity | NPD5402 | Approved |
0.7785 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD7251 | Discontinued |
0.773 | Intermediate Similarity | NPD7808 | Phase 3 |
0.773 | Intermediate Similarity | NPD3268 | Approved |
0.773 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.773 | Intermediate Similarity | NPD2313 | Discontinued |
0.7724 | Intermediate Similarity | NPD6100 | Approved |
0.7724 | Intermediate Similarity | NPD6099 | Approved |
0.7718 | Intermediate Similarity | NPD7390 | Discontinued |
0.7714 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7692 | Intermediate Similarity | NPD230 | Phase 1 |
0.7673 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7669 | Intermediate Similarity | NPD6559 | Discontinued |
0.7655 | Intermediate Similarity | NPD7033 | Discontinued |
0.7655 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7626 | Intermediate Similarity | NPD2797 | Approved |
0.7622 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7606 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7591 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7582 | Intermediate Similarity | NPD3226 | Approved |
0.7576 | Intermediate Similarity | NPD1241 | Discontinued |
0.7569 | Intermediate Similarity | NPD1933 | Approved |
0.7569 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7554 | Intermediate Similarity | NPD3225 | Approved |
0.7554 | Intermediate Similarity | NPD1876 | Approved |
0.7534 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7532 | Intermediate Similarity | NPD919 | Approved |
0.7517 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD1470 | Approved |
0.75 | Intermediate Similarity | NPD1164 | Approved |
0.7485 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7483 | Intermediate Similarity | NPD3764 | Approved |
0.7483 | Intermediate Similarity | NPD411 | Approved |
0.7482 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7468 | Intermediate Similarity | NPD7458 | Discontinued |
0.7464 | Intermediate Similarity | NPD1201 | Approved |
0.7462 | Intermediate Similarity | NPD9266 | Approved |
0.7462 | Intermediate Similarity | NPD74 | Approved |
0.7448 | Intermediate Similarity | NPD447 | Suspended |
0.7447 | Intermediate Similarity | NPD1019 | Discontinued |
0.7439 | Intermediate Similarity | NPD1729 | Discontinued |
0.7438 | Intermediate Similarity | NPD1247 | Approved |
0.7432 | Intermediate Similarity | NPD2346 | Discontinued |
0.7413 | Intermediate Similarity | NPD3027 | Phase 3 |
0.741 | Intermediate Similarity | NPD1608 | Approved |
0.74 | Intermediate Similarity | NPD7003 | Approved |
0.7394 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7394 | Intermediate Similarity | NPD9494 | Approved |
0.7391 | Intermediate Similarity | NPD5711 | Approved |
0.7391 | Intermediate Similarity | NPD5710 | Approved |
0.7389 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7385 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.7385 | Intermediate Similarity | NPD9263 | Approved |
0.7385 | Intermediate Similarity | NPD9264 | Approved |
0.7385 | Intermediate Similarity | NPD9267 | Approved |
0.7376 | Intermediate Similarity | NPD3267 | Approved |
0.7376 | Intermediate Similarity | NPD3266 | Approved |
0.7372 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7368 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7365 | Intermediate Similarity | NPD5408 | Approved |
0.7365 | Intermediate Similarity | NPD5404 | Approved |
0.7365 | Intermediate Similarity | NPD5405 | Approved |
0.7365 | Intermediate Similarity | NPD5406 | Approved |
0.7361 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7349 | Intermediate Similarity | NPD6104 | Discontinued |
0.7342 | Intermediate Similarity | NPD4288 | Approved |
0.7342 | Intermediate Similarity | NPD2296 | Approved |
0.7299 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7286 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7283 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7283 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7279 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7266 | Intermediate Similarity | NPD846 | Approved |
0.7266 | Intermediate Similarity | NPD940 | Approved |
0.7266 | Intermediate Similarity | NPD3847 | Discontinued |
0.7261 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.726 | Intermediate Similarity | NPD3140 | Approved |
0.726 | Intermediate Similarity | NPD4307 | Phase 2 |
0.726 | Intermediate Similarity | NPD3142 | Approved |
0.7241 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7241 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7241 | Intermediate Similarity | NPD6798 | Discontinued |
0.7237 | Intermediate Similarity | NPD2354 | Approved |
0.7226 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7222 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7214 | Intermediate Similarity | NPD1535 | Discovery |
0.7211 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7211 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7208 | Intermediate Similarity | NPD4662 | Approved |
0.7208 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7208 | Intermediate Similarity | NPD4661 | Approved |
0.72 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7195 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7194 | Intermediate Similarity | NPD17 | Approved |
0.7174 | Intermediate Similarity | NPD1894 | Discontinued |
0.7172 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7168 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7163 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7153 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7153 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7151 | Intermediate Similarity | NPD4287 | Approved |
0.7143 | Intermediate Similarity | NPD6971 | Discontinued |
0.7143 | Intermediate Similarity | NPD1613 | Approved |
0.7143 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD4357 | Discontinued |
0.7132 | Intermediate Similarity | NPD9281 | Approved |
0.7124 | Intermediate Similarity | NPD3887 | Approved |
0.7122 | Intermediate Similarity | NPD9268 | Approved |
0.7122 | Intermediate Similarity | NPD1651 | Approved |
0.7113 | Intermediate Similarity | NPD4749 | Approved |
0.7108 | Intermediate Similarity | NPD3751 | Discontinued |
0.7107 | Intermediate Similarity | NPD6844 | Discontinued |
0.7107 | Intermediate Similarity | NPD6280 | Approved |
0.7107 | Intermediate Similarity | NPD6279 | Approved |
0.7103 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7095 | Intermediate Similarity | NPD6355 | Discontinued |
0.7091 | Intermediate Similarity | NPD2403 | Approved |
0.7086 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
PubChem CID   | 5356121 |
ChEMBL   | CHEMBL104255 |
ZINC   |
Molecular Weight:   | 284.10 |
ALogP:   | -0.4666 |
MLogP:   | 2.89 |
XLogP:   | 4.857 |
# Rotatable Bonds:   | 8 |
Polar Surface Area:   | 55.76 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 1 |
# Rings:   | 2 |
# Heavy Atoms:   | 21 |